Leeward Investments LLC MA Has $8.81 Million Stake in Innospec Inc. (NASDAQ:IOSP)

Leeward Investments LLC MA decreased its position in Innospec Inc. (NASDAQ:IOSPFree Report) by 6.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 80,030 shares of the specialty chemicals company’s stock after selling 5,974 shares during the period. Leeward Investments LLC MA owned approximately 0.32% of Innospec worth $8,808,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Hudson Edge Investment Partners Inc. increased its stake in Innospec by 4.9% in the fourth quarter. Hudson Edge Investment Partners Inc. now owns 4,923 shares of the specialty chemicals company’s stock valued at $542,000 after purchasing an additional 230 shares in the last quarter. Principal Financial Group Inc. boosted its holdings in Innospec by 3.5% during the fourth quarter. Principal Financial Group Inc. now owns 129,448 shares of the specialty chemicals company’s stock worth $14,247,000 after purchasing an additional 4,376 shares during the last quarter. State of New Jersey Common Pension Fund D boosted its holdings in Innospec by 3.3% during the fourth quarter. State of New Jersey Common Pension Fund D now owns 17,989 shares of the specialty chemicals company’s stock worth $1,980,000 after purchasing an additional 580 shares during the last quarter. New York State Teachers Retirement System boosted its holdings in Innospec by 1.4% during the fourth quarter. New York State Teachers Retirement System now owns 14,981 shares of the specialty chemicals company’s stock worth $1,649,000 after purchasing an additional 200 shares during the last quarter. Finally, Pacer Advisors Inc. purchased a new position in Innospec during the fourth quarter worth about $53,457,000. Institutional investors and hedge funds own 96.64% of the company’s stock.

Innospec Stock Up 0.3 %

IOSP opened at $103.46 on Friday. The stock has a market cap of $2.58 billion, a price-to-earnings ratio of 72.86 and a beta of 1.09. Innospec Inc. has a twelve month low of $99.49 and a twelve month high of $133.71. The company’s 50-day moving average price is $110.87 and its two-hundred day moving average price is $112.39.

Innospec (NASDAQ:IOSPGet Free Report) last released its earnings results on Tuesday, February 18th. The specialty chemicals company reported $1.41 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.05. The firm had revenue of $466.80 million for the quarter, compared to analysts’ expectations of $447.43 million. Innospec had a net margin of 1.93% and a return on equity of 12.27%. As a group, sell-side analysts anticipate that Innospec Inc. will post 6.18 earnings per share for the current year.

Analysts Set New Price Targets

Separately, StockNews.com cut shares of Innospec from a “strong-buy” rating to a “buy” rating in a report on Saturday, January 11th.

Get Our Latest Research Report on Innospec

Innospec Company Profile

(Free Report)

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

Further Reading

Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSPFree Report).

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.